ECSP982396A - Composiciones que contienen tetrahidrolipstatina - Google Patents
Composiciones que contienen tetrahidrolipstatinaInfo
- Publication number
- ECSP982396A ECSP982396A ECSP982396A ECSP982396A EC SP982396 A ECSP982396 A EC SP982396A EC SP982396 A ECSP982396 A EC SP982396A EC SP982396 A ECSP982396 A EC SP982396A
- Authority
- EC
- Ecuador
- Prior art keywords
- tetrahydrolypstatin
- compositions containing
- product
- compositions
- particles
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- AHLBNYSZXLDEJQ-UHFFFAOYSA-N N-formyl-L-leucylester Natural products CCCCCCCCCCCC(OC(=O)C(CC(C)C)NC=O)CC1OC(=O)C1CCCCCC AHLBNYSZXLDEJQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El invento se refiere a un producto conteniendo tetrahidrolipstatina como ingrediente activo y excipientes farmacéuticamente aceptables, caracterizado porque está en forma de partículas como un diámetro de 0.25 a 2mm; y preparaciones o composiciones farmacéuticas para administración oral que contiene dicho producto.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982396 ECSP982396A (es) | 1998-02-04 | 1998-02-04 | Composiciones que contienen tetrahidrolipstatina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982396 ECSP982396A (es) | 1998-02-04 | 1998-02-04 | Composiciones que contienen tetrahidrolipstatina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982396A true ECSP982396A (es) | 1999-01-12 |
Family
ID=42043319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982396 ECSP982396A (es) | 1998-02-04 | 1998-02-04 | Composiciones que contienen tetrahidrolipstatina |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982396A (es) |
-
1998
- 1998-02-04 EC ECSP982396 patent/ECSP982396A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2156028T3 (es) | Composiciones que contienen tetrahidrolipstatina | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
| IL138767A0 (en) | Anticancer compositions | |
| TW355683B (en) | Composition containing micronized nebivolol | |
| EE9900288A (et) | Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks | |
| ATE333265T1 (de) | Oral anzuwendende schnell zerfallende feste darreichungsformen | |
| HRP20020088B1 (hr) | Levodopa/karbidopa/entakapon farmaceutski pripravak | |
| MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
| DE69923336D1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| BR0112847A (pt) | Uso de uma forma de dosagem sólida | |
| MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
| MXPA03005221A (es) | Composicion farmaceutica de dronedarona para administracion parenteral. | |
| AR032614A1 (es) | Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina | |
| SE0001916D0 (sv) | Novel formulation | |
| HRP20020258B1 (hr) | Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva | |
| MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| BE2016C017I2 (es) | ||
| ECSP982396A (es) | Composiciones que contienen tetrahidrolipstatina | |
| MXPA02006034A (es) | Formas de dosis mucosaloral de apomorfina. | |
| ITMI20020872A1 (it) | Derivati dell'iperforina loro uso e formulazioni che li contengono | |
| ATE301469T1 (de) | Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase |